Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Cardiovascular Outcomes Following Treatment With Alogliptin in Addition to Standard of Care in Subjects With Type 2 Diabetes and Acute Coronary Syndrome
alogliptin
SYR-322_402
NCT00968708
2009-011222-34
Diabetes Mellitus, Type 2
Phase 3
 
May 2015

Powered by ideaPoint, Inc.